Aldose reductase interacts with AKT1 to augment hepatic AKT/mTOR signaling and promote hepatocarcinogenesis.
Zhao JX, Yuan YW, Cai CF, Shen DY, Chen ML, Ye F, Mi YJ, Luo QC, Cai WY, Zhang W, Long Y, Zeng Y, Ye GD, Yang SY.
Zhao JX, et al.
Oncotarget. 2017 May 10;8(40):66987-67000. doi: 10.18632/oncotarget.17791. eCollection 2017 Sep 15.
Oncotarget. 2017.
PMID: 28978011
Free PMC article.